1. Home
  2. TRI vs IDXX Comparison

TRI vs IDXX Comparison

Compare TRI & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thomson Reuters Corp

TRI

Thomson Reuters Corp

HOLD

Current Price

$122.01

Market Cap

55.2B

Sector

N/A

ML Signal

HOLD

Logo IDEXX Laboratories Inc.

IDXX

IDEXX Laboratories Inc.

HOLD

Current Price

$691.16

Market Cap

57.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRI
IDXX
Founded
1851
1983
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.2B
57.1B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
TRI
IDXX
Price
$122.01
$691.16
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
$190.67
$700.50
AVG Volume (30 Days)
941.3K
430.3K
Earning Date
02-05-2026
02-02-2026
Dividend Yield
1.98%
N/A
EPS Growth
N/A
21.65
EPS
3.88
12.60
Revenue
$7,376,000,000.00
$4,167,411,000.00
Revenue This Year
$4.06
$12.15
Revenue Next Year
$7.75
$8.72
P/E Ratio
$30.96
$55.27
Revenue Growth
2.96
8.39
52 Week Low
$118.64
$356.14
52 Week High
$218.42
$769.98

Technical Indicators

Market Signals
Indicator
TRI
IDXX
Relative Strength Index (RSI) 33.01 44.93
Support Level $118.64 $681.00
Resistance Level $129.89 $709.24
Average True Range (ATR) 3.13 17.53
MACD -0.61 -1.26
Stochastic Oscillator 25.07 42.89

Price Performance

Historical Comparison
TRI
IDXX

About TRI Thomson Reuters Corp

Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.

About IDXX IDEXX Laboratories Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Share on Social Networks: